Graves Orbitopathy clinical trials

Explore recruiting graves orbitopathy clinical trials.

Recruiting graves orbitopathy studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Graves Orbitopathy trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

The use of [68Ga]Ga-FAPI PET/MRI in assessing disease activity in patients with Graves’ orbitopathy

Netherlands

Phase I and Phase II (Integrated)- Other EU CTIS Study details

A phase III, randomized, controlled, open label, no profit, single-center intervention study to compare the effect of a conservative (antithyroid drugs) and an ablative approach (radioiodine or total thyroidectomy) for the treatment of hyperthyroidism in patients with Graves’ disease and moderate-to-severe and active Graves’ Orbitopathy (GO) treated with intravenous glucocorticoids (ABLAGO Study)

Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

A multiple ascending dose (MAD) safety, tolerability and efficacy study of VRDN-001, a humanized monoclonal antibody directed against the IGF-1 receptor, in normal healthy volunteers (NHVs) and subjects with thyroid eye disease (TED)

Spain, Germany, France, Netherlands

Phase II and Phase III (Integrated) EU CTIS Study details

Graves Orbitopathy trials by city

Graves Orbitopathy in Toronto Graves Orbitopathy in Vancouver Graves Orbitopathy in Montreal Graves Orbitopathy in Calgary Graves Orbitopathy in Edmonton Graves Orbitopathy in Ottawa Graves Orbitopathy in Winnipeg Graves Orbitopathy in Quebec City Graves Orbitopathy in Hamilton Graves Orbitopathy in Kitchener Graves Orbitopathy in London Graves Orbitopathy in Halifax Graves Orbitopathy in New York Graves Orbitopathy in Los Angeles Graves Orbitopathy in Chicago Graves Orbitopathy in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease